Neurogenesis within the hippocampus after chronic methylphenidate exposure

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Adult neurogenesis occurs in the hippocampus and is influenced by psychoactive drugs.
• The precise effects of methylphenidate on neurogenesis remain incompletely understood.
• Methylphenidate is a common psychostimulant for treating attention deficit hyperactivity disorder.

Purpose of the Study:

• To investigate the impact of chronic low and high-dose methylphenidate on hippocampal neurogenesis.
• To determine the long-term survival of newly generated neurons under different methylphenidate treatment regimens.
• To explore the underlying molecular mechanisms, including key protein levels, affected by methylphenidate.

Main Methods:

• Mice received chronic low (1 mg/kg) and high (10 mg/kg) intraperitoneal doses of methylphenidate.
• Neurogenesis was assessed after 28 and 56 days of treatment.
• Levels of proteins including VEGF, TrkB, and beta-catenin were measured in the hippocampus.

Main Results:

• Methylphenidate at both doses increased neurogenesis, but newly generated cells did not survive if treatment ceased.
• Continued low-dose treatment promoted survival of new neurons, associated with increased hippocampal VEGF, TrkB, and beta-catenin.
• High-dose treatment led to decreased beta-catenin (28 days) and VEGF, beta-catenin, TrkB (56 days), impairing long-term neuron survival.

Conclusions:

• Low-dose methylphenidate enhances hippocampal cell proliferation and survival, potentially mediated by VEGF, TrkB, and beta-catenin.
• High-dose methylphenidate may initially promote proliferation but compromises long-term neuronal survival due to reduced key protein levels.
• Treatment duration and dosage are critical factors in methylphenidate's effects on adult hippocampal neurogenesis.